Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence.

Kooter AJ, Kostense PJ, Groenewold J, Thijs A, Sattar N, Smulders YM.

Circulation. 2011 Aug 9;124(6):741-5. doi: 10.1161/CIRCULATIONAHA.111.035725. No abstract available.

2.

Cardiovascular risk prediction: basic concepts, current status, and future directions.

Lloyd-Jones DM.

Circulation. 2010 Apr 20;121(15):1768-77. doi: 10.1161/CIRCULATIONAHA.109.849166. Review. No abstract available.

4.

Cardiovascular disease: strategies for risk assessment and modification.

Braun LT.

J Cardiovasc Nurs. 2006 Nov-Dec;21(6 Suppl 1):S20-42; quiz S43-5. Review.

PMID:
17293747
5.

Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.

Dennison CR, Hughes S.

J Cardiovasc Nurs. 2009 Jan-Feb;24(1):18-20. doi: 10.1097/01.JCN.0000343558.14237.70. Review. No abstract available.

PMID:
19114796
6.

Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.

Morimoto T, Fukui T, Lee TH, Matsui K.

Am J Med. 2004 Oct 1;117(7):459-68. Review.

PMID:
15464702
7.

Critical review of the ACC/AHA algorithm for stratifying cardiac patients for noncardiac surgery.

Park KW.

Int Anesthesiol Clin. 2001 Fall;39(4):81-92. Review. No abstract available.

PMID:
11581538
8.

New risk factors for atherosclerosis and patient risk assessment.

Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P.

Circulation. 2004 Jun 15;109(23 Suppl 1):III15-9. Review.

9.

The challenges and benefits of cardiovascular risk assessment in clinical practice.

Grover SA, Lowensteyn I.

Can J Cardiol. 2011 Jul-Aug;27(4):481-7. doi: 10.1016/j.cjca.2011.04.008. Review. English, French.

PMID:
21684717
10.

Metabolic syndrome and cardiometabolic risk: an update.

Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bombelli M, Mancia G.

Blood Press. 2009;18(1-2):7-16. doi: 10.1080/08037050802677695. Review.

PMID:
19148840
11.

[Non-communicable chronic diseases in Brazil: from risk factors to social impact].

Lessa I, Mendonça GA, Teixeira MT.

Bol Oficina Sanit Panam. 1996 May;120(5):389-413. Review. Portuguese.

PMID:
8924219
12.

Current and future directions of cardiovascular risk prediction.

Smith SC Jr.

Am J Cardiol. 2006 Jan 16;97(2A):28A-32A. Epub 2005 Dec 1. Review.

PMID:
16442934
13.

Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease.

Benvenuto LJ, Krakoff LR.

Am J Hypertens. 2011 Feb;24(2):135-44. doi: 10.1038/ajh.2010.146. Epub 2010 Sep 2. Review.

PMID:
20814408
Items per page

Supplemental Content

Write to the Help Desk